Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New antidepressant and cognition enhancer developed in Russia

Nov. 17, 1997

Anesta's Actiq denied FDA approval

Nov. 17, 1997

Anticonvulsants with reduced side effects from RCT

Nov. 17, 1997

Brain GABA-A receptor ligands prepared at Neurogen

Nov. 17, 1997

Aradigm tests inhalation form of morphine in volunteers

Nov. 14, 1997

nNOS inhibitor from Astra effective in animal models of stroke, ALS

Nov. 14, 1997

Roche in-licenses promising antiparkinsonian agent

Nov. 14, 1997

CCK/gastrin receptor ligands from James Black Foundation

Nov. 13, 1997

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

FDA review of Myotrophin continues after resubmission

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...